Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
5.85
+0.22 (3.91%)
At close: Feb 18, 2026, 4:00 PM EST
5.73
-0.12 (-2.02%)
After-hours: Feb 18, 2026, 5:33 PM EST
Candel Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
38
Market Cap
321.16M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 125.00K | - | - |
| Dec 31, 2021 | 125.00K | - | - |
| Dec 31, 2020 | 125.00K | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Century Therapeutics | 113.34M |
| XOMA Royalty | 47.11M |
| Fennec Pharmaceuticals | 38.79M |
| X4 Pharmaceuticals | 33.98M |
| Foghorn Therapeutics | 24.52M |
| AC Immune | 5.48M |
| Armata Pharmaceuticals | 5.05M |
CADL News
- 7 days ago - Candel Therapeutics to Present at the 7th Annual Glioblastoma Drug Development Summit - GlobeNewsWire
- 16 days ago - Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 3 months ago - Candel Therapeutics to Host Virtual R&D Event on December 5, 2025 - GlobeNewsWire
- 3 months ago - Candel Therapeutics Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 3 months ago - Candel Therapeutics Showcases Immunotherapy Leadership at SITC 2025, Demonstrating Integration of Clinical Innovation, Multi-Omics, and Artificial Intelligence to Advance Next-Generation Immunotherapies in Solid Tumors - GlobeNewsWire
- 3 months ago - Candel Therapeutics to Present at Jefferies Global Healthcare Conference in London - GlobeNewsWire
- 4 months ago - Candel Therapeutics Appoints Leading Systems Immunology Expert Bali Pulendran, Ph.D., to Research Advisory Board - GlobeNewsWire
- 4 months ago - Candel Therapeutics Enters into $130 Million Term Loan Facility with Trinity Capital Inc. - GlobeNewsWire